> For anti-inflammatory doses, you try to find the lowest possible dose
> that will provide anti-inflammatory properties. It is lower than
> anti-infective doses. There are companies working on creating
> derivatives of macrolides and tetracyclines that have NO antibiotic
> properties, but only anti-inflammatory properties.
I am aware of all of the above. I have read the CHEST article (and many
other PubMed articles on the same topic). I was not sure if I had a
low-level chronic infection (which would require a slightly higher
dose) or if the anti-inflammatory properties would be the main benefit.
I am young, my liver enzymes are good, and there was no problem with
selecting the high dose for a trial period of two months.
> I have read asthmastory, and communicated with the physician. It's an
> interesting theory, but not widely accepted.
It is becoming *extremely* widely accepted . . . see www.cpnhelp.org,
for one example.
> So, you were essentially trying to treat the infection with two full
> dose macrolides and one worked the other didn't: perhaps you've become
> resistant to macrolides.
You mean the pathogen has become resistant, I presume?
Another options is that there's a pathogen involved that is only
partially susceptible to macrolides. A swab or IgG assay may be the
next step. Pseodomonas, golden staph etc. could probably cause the same
symptoms.
> If you read the Chest article, and the other articles on macrolides
> as anti-inflammatories, they are used at low doses, with no goal of
> curing infection--just preventing an inflammatory response that may
> predispose to infection.
Fully aware of that, thanks.
Nick